---
title: "AURUM PHARMACEUTICALS LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/0faabc0b-3944-56a4-8b59-bbbfb9ece283
json: https://whiteintel.dev/api/public/dossier/0faabc0b-3944-56a4-8b59-bbbfb9ece283
identifier: oo:GB-COH-02581060
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# AURUM PHARMACEUTICALS LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-02581060`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/0faabc0b-3944-56a4-8b59-bbbfb9ece283  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/0faabc0b-3944-56a4-8b59-bbbfb9ece283  

## Ownership & control

### Owners / controllers

- **MACARTHYS LABORATORIES LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/808792e2-ba67-58e7-b32b-03e49b9e7229
- **Macarthys Laboratories Limited** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/af48f189-d6b7-473f-bd6b-21f3e8a80b53

### UBO chain (walk to the ultimate owner)

A **7-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `02581060`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 1991-02-08
- **Registered office:** Bampton Road, Romford, Essex, RM3 8UG
- **SIC:** 21100, 46460

### Officers

- RUYANT, Foucauld — secretary · appointed 2024-09-30
- DE ULTRA DE SOUSA BARCELOS, Bruno — director · Portuguese · appointed 2023-01-17
- LASSERRE, Xavier Pierre Christian — director · French · appointed 2023-06-26
- MEHRAI, Alexander — director · British · appointed 2026-03-30
- RUYANT, Foucauld — director · French · appointed 2024-09-30
- COMERFORD, Martin James — secretary · British · appointed 2002-03-31 · resigned 2006-02-28
- EARNSHAW, Jeremy Waring — secretary · British · appointed 2000-12-11 · resigned 2005-09-30
- KNIGHT, Anthony — secretary · British · appointed 2007-07-13 · resigned 2010-06-30
- LANNING, Linda Rosemary — secretary · British · resigned 1999-06-09
- LOFTHOUSE, Stephen David — secretary · British · appointed 2006-03-06 · resigned 2006-11-03
- PINCHIN, Nicholas John — secretary · British · appointed 1999-06-09 · resigned 2000-12-11
- WEST, David William — secretary · English · appointed 2006-11-03 · resigned 2007-07-12
- EVERSECRETARY LIMITED — corporate secretary · appointed 2005-09-30 · resigned 2006-03-06
- BOVOLENTA, Andrea — director · Italian · appointed 2024-03-01 · resigned 2024-06-05
- BRYANT, Derek — director · British · appointed 1999-06-09 · resigned 2002-03-31
- COMERFORD, Martin James — director · British · appointed 2002-03-31 · resigned 2006-02-28
- DE SOUZA, Richard Anthony — director · British · appointed 2010-09-28 · resigned 2014-01-06
- DELUARD, Bertrand — director · French · appointed 2019-03-11 · resigned 2022-09-13
- EARNSHAW, Jeremy Waring — director · British · appointed 2000-12-11 · resigned 2005-09-30
- ENGELEN, Thomas — director · Netherlands · appointed 2010-05-12 · resigned 2011-11-15

### Beneficial owners (Persons with Significant Control)

- [Orphea Limited](https://whiteintel.dev/entity/778f04de-400a-5c68-b743-5127129f310e) — 75–100% shares · corporate PSC · United Kingdom — since 2023-08-30
- [Macarthys Laboratories Limited](https://whiteintel.dev/entity/af48f189-d6b7-473f-bd6b-21f3e8a80b53) — 75–100% shares · corporate PSC · England — ceased 2023-08-30

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/02581060
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/02581060

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **AURUM PHARMACEUTICALS LIMITED**. Human view: https://whiteintel.dev/entity/0faabc0b-3944-56a4-8b59-bbbfb9ece283 · Structured JSON: https://whiteintel.dev/api/public/dossier/0faabc0b-3944-56a4-8b59-bbbfb9ece283._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._